:: UI - Tugas Akhir :: Kembali

UI - Tugas Akhir :: Kembali

Pengaruh fluoxetine terhadap peningkatan kadar penderita depresi pasca sindrom koroner akut = The Influence of fluoxetine in nitric oxide level in patients with post acute coronary syndrome depression

Noor Asyiqah Sofia; Hamzah Shatri, supervisor; Agus Siswanto, supervisor; Kuntjoro Harimurti, supervisor; Cosphiadi Irawan, examiner; Habibah Hanum N, examiner; E. Mudjaddid, examiner; Widayat Djoko Santoso, examiner; Marbun, Maruhum Bonar H., examiner ([Publisher not identified] , 2015)

 Abstrak

ABSTRAK
Latar Belakang. Depresi sering terjadi pada penderita sindroma koroner akut
(SKA) dan berhubungan dengan peningkatan mortalitas penderita SKA. Obat
selective serotonin reuptake inhibitor (SSRI) telah diketahui efikasinya pada
depresi pasca SKA. Nitric oxide (NO) merupakan salah satu penanda fungsi
endotel. Studi menunjukkan kemampuan SSRI citalopram dalam memperbaiki
fungsi endotel melalui peningkatan kadar nitric oxide (NO). Fluoxetine
merupakan obat SSRI yang tersedia dengan baik di Indonesia belum pernah
diteliti pengaruhnya pada peningkatan kadar NO.
Tujuan. Mengetahui pengaruh pemberian fluoxetine 20 mg/hari selama 8 minggu
terhadap peningkatan kadar NO pasien depresi pasca SKA, serta Mengetahui
korelasi antara perbaikan simtom depresi dengan peningkatan kadar NO pasien
depresi pasca SKA yang mendapatkan fluoxetine 20 mg/hari selama 8 minggu.
Metode. Penelitian uji klinik tersamar acak ganda yang dilakukan pada JanuariSeptember
2015
di
poklinik
Jantung
RSUP
Dr.Sardjito
Yogyakarta.
Subjek
adalah
penderita
pasca SKA usia 40-60 tahun yang memenuhi kriteria depresi. Subjek
dirandomisasi untuk mendapatkan fluoxetine dosis 20 mg/hari selama 8 minggu
atau plasebo. Simtom depresi yang diukur dengan kuesioner BDI dan kadar NO
diambil pada awal dan akhir minggu ke 8 penelitian.
Hasil. Dari 44 subjek yang mengikuti penelitian, 24 subjek mendapatkan
fluoxetine dan 20 subjek mendapatkan plasebo. Analisis dilakukan pada 19 subjek
kelompok fluoxetine dan 19 subjek kelompok plasebo. Rerata kadar NO sebelum
dan sesudah pemberian fluoxetine adalah berturut-turut 31,86(2,4) μm dan
29,7(2,7) μm. Rerata kadar NO sebelum dan sesudah pemberian plasebo adalah
berturut-turut 32,44(2,48) μm dan 30,09(2,87) μm. Tidak terdapat korelasi antara
perbaikan simtom depresi dan peningkatan kadar NO pada pasien depresi pasca
SKA yang mendapatkan fluoxetine dibandingkan kelompok plasebo (r -0,206; p
0,215).
Simpulan. Fluoxetine dosis 20 mg/hari selama 8 minggu pada pasien depresi
pasca SKA tidak meningkatkan kadar NO. Penurunan skor BDI pasien depresi
pasca SKA yang mendapatkan fluoxetine 20 mg/hari selama 8 minggu tidak berkorelasi dengan peningkatan kadar NO.

ABSTRACT
Background. Depression was prevalent in post acute coronary syndrome (ACS)
patients and this condition was related with increasing morbidity and mortality.
selective serotonin reuptake inhibitor has established as a treatment choice for
depression in post ACS patients. Nitric oxide (NO) was a well known marker of
endothelial function. Study on SSRI Citalopram showed an increasing level of NO
after administration of citalopram. Fluoxetine was available in Indonesia, but its
function in improving endothelial function through the increasing of NO level
remains unknown.
Purpose. To evaluate the influence of fluoxetine 20 mg daily for 8 weeks in
increasing NO level in patients post ACS with depression, and to evaluate the
correlation between improvement in depressive symptoms and increment of NO
level in post ACS depression patients who receive fluoxetine 20 mg daily for 8
weeks.
Method. It was a randomized double blind clinical trial counducted in JanuarySeptember
2015 whic held in Sardjito General Hospital Yogyakarta. Eligible
subjects were post ACS age 40-60 years who fulfilled depression criteria. Subjects
were randomized to receive fluoxetine 20 mg daily or plasebo for 8 weeks.
Depressive symtoms were evaluate using BDI inventory. Nitric oxide level were
taken at baseline and the end of week 8.
Results. From 44 subjects, 24 subjects received fluoxetine, while 20 subjectcs
received placebo. Analysis was done in 19 subjects of fluoxetine group and 19
subjects of plasebo group. Means of NO level before and after treatment in
fluoxetine group were 31,86(2,4) μm and 29,7(2,7) μm respectively. We found no
correlation between improvement of depressive symptoms and increment of NO
level (r -0,206; p 0,215).
Conclusions. The NO level was not increased in post ACS depression patients
who recieve fluoxetine 20 mg daily for 8 weeks. The improvement of depressive
symptoms was not correlated with increment of NO level in post ACS patients depression patients who recieve fluoxetine 20 mg daily for 8 weeks.

 File Digital: 1

Shelf
 SP-Noor Asyiqah Sofia.pdf :: Unduh

LOGIN required

 Metadata

No. Panggil : SP-Pdf
Entri utama-Nama orang :
Entri tambahan-Nama orang :
Entri tambahan-Nama badan :
Subjek :
Penerbitan : [Place of publication not identified]: [Publisher not identified], 2015
Program Studi :
Bahasa : ind
Sumber Pengatalogan : LibUI ind rda
Tipe Konten : text
Tipe Media : computer
Tipe Carrier : online resource
Deskripsi Fisik : xvii, 47 pages : illustration ; 28 cm + appendix
Naskah Ringkas :
Lembaga Pemilik : Universitas Indonesia
Lokasi : Perpustakaan UI, Lantai 3
  • Ketersediaan
  • Ulasan
No. Panggil No. Barkod Ketersediaan
SP-Pdf 16-18-363892577 TERSEDIA
Ulasan:
Tidak ada ulasan pada koleksi ini: 20424509